Cargando…
EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
BACKGROUND: Immunotherapy is an effective therapeutic approach for multiple human cancer types. However, the correlations between EVA1C and patients’ prognosis as well as immune infiltration remain obscure. Herein, we employed transcriptomic and clinical data extracted from two independent databases...
Autores principales: | Hu, Zhicheng, Qu, Shanqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277382/ https://www.ncbi.nlm.nih.gov/pubmed/34267752 http://dx.doi.org/10.3389/fimmu.2021.683572 |
Ejemplares similares
-
EVA1B to Evaluate the Tumor Immune Microenvironment and Clinical Prognosis in Glioma
por: Qu, Shanqiang, et al.
Publicado: (2021) -
Upregulation of Piezo1 Is a Novel Prognostic Indicator in Glioma Patients
por: Qu, Shanqiang, et al.
Publicado: (2020) -
PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
por: Li, Peng, et al.
Publicado: (2022) -
Bevacizumab in recurrent WHO grades II–III glioma
por: Annakib, Soufyan, et al.
Publicado: (2023) -
Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma
por: Wang, Xiao, et al.
Publicado: (2022)